The FDA recognizes expiration dates as critical safety markers
First of all, every time you loose weight, you will also loose lean mass
These findings support the concept that glucagon receptor activation may be therapeutically useful when balanced by GLP-1 receptor signaling, although retatrutide currently provides the most prominent evidence for triple receptor agonism
They may adjust your dosage or suggest an alternative medication
If you would like to schedule an initial consultation to inquire about the weight loss therapies that we offer, you wish to lose weight and optimize your health, or you are interested in scheduling a healthcare/telehealth visit, please be sure to reach out to us
Many patients who have been prescribed dulaglutide have not required hospitalization or medical treatment to address the side effects theyve experienced while on a GLP-1